Image
10.33826/IJMRAS/V05i06.7

CONGENITAL NEPHROTIC SYNDROME: A CASE REPORT

Abstract

Congenital nephrotic syndrome (CNS) is a rare kidney disorder characterized by severe protein urea, hypo-protein aemia, and edema commencing shortly after birth. The majority CNS type often discovered is Finnish by common indication of prematurely born infant with a large placenta. Prenatal diagnosis can be through the detection of high levels of Alfa fetoprotein in the amniotic fluid. The infant aged one month 18 days had abdominal swelling that was noticeable from 21 days after birth. The infant hospitalized at Kolaka Hospital had anasarca edema, hypo-albuminemia (albumin 1.0 g / dl), protein urea (+++), and hyper-lipidaemia (209). Patient’s history of receiving albumin transfusions. Referring to the anamnesis and physical examination, the infant endured a CNS started less than three months after birth, and the onset factor of symptoms led to primary CNS due to genetic disorders.

The diagnosis is made based on history, physical examination, and supporting investigations. The patient accepts the treatment of intravenous albumin transfusion followed by intravenous antibiotics for secondary infection.

Keywords
  • Congenital,
  • Nephrotic syndrome,
  • Child Health.
References
  • Albar,H. and Bilondatu,F.. Profile of Pediatric Nephrotic Syndrome in Wahidin Sudirohusodo Hospital, Makassar, Indonesia. 2019. CDK-274/ vol. 46, No. 3
  • Mishra,O.P.et al. Can We Predict Relapses in Children with Idiopathic Steroid-Sensitive Nephrotic Syndrome.India. Journal Of Tropical Pediatric.2013; Vol. 59, No. 5
  • Kher,K.K .Clinical Pediatric Nephrology: Nephrotic Syndrome 3rded.CRC Press.2017;pp.286-97
  • Uwaezuoke,S.N.Steroid-sensitive nephrotic syndrome in children: triggers of relapse and evolving hypotheses on pathogenesis. Italian Journal of Pediatrics .2015;41:19 DOI 10.1186/s13052-015-0123-9
  • Willicombe,M.Thomas,D. and McAdoo,S.COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?.JASN.2020; doi:
  • https://doi.org/10.1681/ASN.2020030348
  • Lotfi,B ,Farshid.S, Dadashzadeh.N, Valizadeh.R, and Mohsen.R. Is Coronavirus Disease 2019(COVID-19) Associated with Renal Involvement A Review of Century Infection. Jandishapur J Microbiol.2020.doi:10.5812/jjm.102899
  • The Jakarta post. Indonesia's latest official COVID-19 figures.https://www.thejakartapost.com/news/2020/03/23/indonesias-latest-covid-19-figures.html. Accessed 20 May 2020.
  • Liu,B.Li,M. Zhoua,Z. Guane,X. Xiang,Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome(CRS).Journal of Autoimmunity. 2019. https://doi.org/10.1016/j.jaut.2020.102452
  • Al Eisa, et al. Urinary excretion of IL-1β, IL-6 and IL-8 cytokines during relapse and remission of idiopathic nephrotic syndrome. Journal of Inflammation Research.2017;10
  • Vaduganathan, M.et al. Renin-Angiotensin-Aldosterone-System Inhibitor in Patient with Covid-19. The New England Journal Medicine.2020; pp 1653-59
  • Su H, Lei C-T and Zhang C. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An update. Front. Immunol. 2017;8:405. doi: 10.3389/fimmu.2017.00405
  • Askanase, AD.Khalili,L.Buyon,JP. Thoughts COVID-19 and Autoimmune Diseases. Lupus Science and Medicine.2020.doi:10.1136/lupus-2020-000396
  • Gandhi,RT,et al. Mild or Moderate. New England Journal of Medicine.2020. doi: 10.1056/NEJMcp2009249
  • Lang, AD. Osterhaus,A, D.M.E. Haagmans,B.L. Interferon-γ and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells. Elsevier Inc. Virology 353 (2006) 474 –481. doi:10.1016/j.virol.2006.06.011
  • Ciaglia,E.Vecchione,C. Puca,AA. COVID-19 Infection and Circulating ACE-2 Levels: Protective Role in Women and Children. Front.Pediatric.2020;8:206.doi : 10.3389/fped.2020.00206
  • Shi,Yufang.et al. COVID-19 infection: the perspectives on immune responses.Cell Death & Differentiation. 2020; 27:14511454.https://doi.org/10.1038/s41418-020-0530-3
  • Marietta, Marco.et al. COVID-19 and hemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus2020; DOI 10.2450/2020.0083-20
  • Hardenberg, job.Favaloro, Emmanuel.COVID-19: progression of the disease and intravascular coagulation – present status and future perspectives. : Department of Hematology, Sydney Centers for Thrombosis and Hemostasis, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westhead Hospital, Westmeath, New South Wales, Australia.2020; https://doi.org/10.1515/cclm-2020-0502
  • Connors, Jean. Levy, Jerrold. COVID-19 and its implications for thrombosis and anticoagulation. American Society of Hematology.2020
  • London Real Army. Interview with Dr. Andrew Kaufman - UNMASKING THE LIES AROUND COVID-19. 2020. Available from : https://anchor.fm/londonrealarmy/support
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Dr. ERNI MURDANINGSIH, Dr. SYARIFUDDIN RAUF, & Dr. JUSLI ARAS. (2022). CONGENITAL NEPHROTIC SYNDROME: A CASE REPORT. International Journal of Multidisciplinary Research and Studies, 5(06), 102–114. https://doi.org/10.33826/ijmras/v05i06.7

Download Citation

Downloads

Download data is not yet available.

Similar Articles

You may also start an advanced similarity search for this article.